Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Metformin treatment rescues CD8+ T-cell response to immune checkpoint inhibitor therapy in mice with NAFLD

Journal of Hepatology(2022)10.1016/j.jhep.2022.03.010Source: DataRank Database

Metformin treatment rescues CD8+ T-cell response to immune checkpoint inhibitor therapy in mice with NAFLD is a research paper published in Journal of Hepatology (2022). On theSindex it has a DataRank of 0. It has been cited 144 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access144 citations

Download PDF

Cite:

Linked data & code

geo

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 18.95)OA: greenTopics (43)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (20)

Justin McCallen ORCID,Olena Kamenyeva ORCID,Benjamin Ruf ORCID,John C. McVey,Juraj Kabát ORCID

Live enrichment

PubMed:35378172 PMC:PMC9391315 OpenAlex:https://openalex.org/W4221049711

Intramural NIH HHS

Grant: ZIA BC011345

Intramural NIH HHS

Grant: ZIA BC011346

FWCI

18.95

Citation Percentile

1.0%

Influential Citations

Citation Trend

2022

2023

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9391315

GREENhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9391315

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9391315

publisherhttps://api.elsevier.com/content/article/PII:S0168827822001787?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0168827822001787?httpAccept=text/plain

Fields of Study

Liver Disease Diagnosis and TreatmentMetabolism, Diabetes, and CancerCancer Immunotherapy and BiomarkersMedicineAnimalsCD8-Positive T-LymphocytesCarcinoma, HepatocellularImmune Checkpoint InhibitorsLiverLiver NeoplasmsMetforminMiceMice, Inbred C57BLNon-alcoholic Fatty Liver Disease

MeSH Terms

Immune Checkpoint InhibitorsAnimalsCarcinoma, HepatocellularLiverLiver NeoplasmsMetforminMice, Inbred C57BLCD8-Positive T-LymphocytesMiceNon-alcoholic Fatty Liver Disease

Keywords

SteatohepatitisMetforminCD8MedicineCancer researchFatty liverHepatocellular carcinomaImmunotherapyImmune systemImmunologyInternal medicineDiseaseInsulinLiver cancermetabolic syndromeImmunometabolismHepatic TranscriptomicsNash ImmunologyHepatic Intravital Imaging

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of Machine learning integrations develop an antigen-presenting-cells and T-Cells-Infiltration derived LncRNA signature for improving clinical outcomes in hepatocellular carcinoma

10.6084/m9.figshare.26578532.v1figshare

Additional file 1 of Machine learning integrations develop an antigen-presenting-cells and T-Cells-Infiltration derived LncRNA signature for improving clinical outcomes in hepatocellular carcinoma

10.6084/m9.figshare.26578532figshare